Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Chemical Communications (Cambridge, England)
|
September 6, 2022
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
Qisi Zhang, Cyrille S Kounde, Milon Mondal, et al.
ACS Chemical Biology
|
June 18, 2026
Sulfonadyn Compounds: A Class of Aryl Sulfonamides That Inhibit Dynamin GTPase and Clathrin-Mediated Endocytosis and Are Antiepileptic in Animal Models
Nigel C Jones, Mark J Robertson, Luke R Odell, et al.
Structure (London, England : 1993)
|
March 20, 2025
Next-generation small molecule inhibitors of clathrin function acutely inhibit endocytosis
André Horatscheck, Michael Krauß, Haydar Bulut, et al.
Cell
|
August 6, 2011
Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition
Lisa von Kleist, Wiebke Stahlschmidt, Haydar Bulut, et al.
The Journal of Cell Biology
|
August 18, 2010
Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells
Mark T Howes, Matthew Kirkham, James Riches, et al.
Plos One
|
September 6, 2017
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
Abiodun D Ogunniyi, Manouchehr Khazandi, Andrew J Stevens, et al.
Journal of Virology
|
October 31, 2014
Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses a clathrin-mediated endocytosis-like pathway
Yíngyún Caì, Elena N Postnikova, John G Bernbaum, et al.
ACS Chemical Biology
|
May 7, 2013
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors
Andrew B McGeachie, Luke R Odell, Annie Quan, et al.
Cancer Research
|
August 16, 2013
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells
Justine R Stehn, Nikolas K Haass, Teresa Bonello, et al.
Science Translational Medicine
|
June 2, 2017
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
Dane D Jensen, TinaMarie Lieu, Michelle L Halls, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Chemical Communications (Cambridge, England)
|
September 6, 2022
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
Qisi Zhang, Cyrille S Kounde, Milon Mondal, et al.
ACS Chemical Biology
|
June 18, 2026
Sulfonadyn Compounds: A Class of Aryl Sulfonamides That Inhibit Dynamin GTPase and Clathrin-Mediated Endocytosis and Are Antiepileptic in Animal Models
Nigel C Jones, Mark J Robertson, Luke R Odell, et al.
Structure (London, England : 1993)
|
March 20, 2025
Next-generation small molecule inhibitors of clathrin function acutely inhibit endocytosis
André Horatscheck, Michael Krauß, Haydar Bulut, et al.
Cell
|
August 6, 2011
Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition
Lisa von Kleist, Wiebke Stahlschmidt, Haydar Bulut, et al.
The Journal of Cell Biology
|
August 18, 2010
Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells
Mark T Howes, Matthew Kirkham, James Riches, et al.
Plos One
|
September 6, 2017
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
Abiodun D Ogunniyi, Manouchehr Khazandi, Andrew J Stevens, et al.
Journal of Virology
|
October 31, 2014
Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses a clathrin-mediated endocytosis-like pathway
Yíngyún Caì, Elena N Postnikova, John G Bernbaum, et al.
ACS Chemical Biology
|
May 7, 2013
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors
Andrew B McGeachie, Luke R Odell, Annie Quan, et al.
Cancer Research
|
August 16, 2013
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells
Justine R Stehn, Nikolas K Haass, Teresa Bonello, et al.
Science Translational Medicine
|
June 2, 2017
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
Dane D Jensen, TinaMarie Lieu, Michelle L Halls, et al.
Page
of 17